Home
Live Updates
Merck acquires EyeBio in up to $3B deal : comparemela.com
Merck acquires EyeBio in up to $3B deal
Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held ophthalmology-focused biotech firm, in a deal valued up to $3 billion....
Related Keywords
Tony Adamis ,
David Guyer ,
Merck Research Laboratories ,
Merck Co Inc ,
Merck Research ,
comparemela.com © 2020. All Rights Reserved.